Show simple item record Földi, Gerda Polgár, Csaba Zongor, Z Melles-Bencsik, Barbara Stelczer, Gábor Madaras, B Pinter, T Jederan, E Lövey, József 2019-11-27T15:14:41Z 2019-11-27T15:14:41Z 2018
dc.identifier.citation journalVolume=62;journalIssueNumber=1;journalTitle=MAGYAR ONKOLÓGIA;pagerange=62-67;journalAbbreviatedTitle=MAGYAR ONKOLÓGIA;
dc.description.abstract Recently the prevalence of oligometastatic patients is increasing. A common site of distant spread is the liver. The standard of care is curative surgical resection, however, the resecability rate is only 10-20%. Alternatively, radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) may be used. Stereotactic ablative body radiotherapy (SABRT) makes it possible to deliver curative radiation dose without radiation injury to the healthy liver tissue. We delivered SABRT to three patients with inoperable hepatic metastases. The primary tumors were rectal (2) and lung (1). The dose was 3x20 Gy every other day. We observed one grade 1 side effect. All the metastases showed complete remission and no local recurrence or late side effect occurred during the one year of follow-up. One patient is tumor-free, one has stable disease, in one patient two new hepatic metastases appeared and receives chemo-biological therapy. SABRT of liver metastases is safe and highly effective. It can be expected that in the near future it will become one of the standard treatments of hepatic tumors.
dc.format.extent 62-67
dc.relation.ispartof urn:issn:0025-0244
dc.title Májáttétes betegek sztereotaxiás ablatív sugárkezelésével (SABRT) elért első eredményeink
dc.type Journal Article 2019-09-26T09:07:27Z
dc.language.rfc3066 hu
dc.rights.holder NULL
dc.identifier.mtmt 3358444
dc.identifier.pubmed 29570188
dc.contributor.department SE/AOK/K/Onkológiai Tanszék
dc.contributor.institution Semmelweis Egyetem

Files in this item



This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account